References
- Son MW, Lim JI, Jung MY, Kim SH, Kim WB, Chang YS, et al. New synthesis of sestamibi and comparison of stability of its formulation. Nucl Med Mol Imag. 2001;35:334-341.
- Taillefer R, Laflamme L, Dupras G, Picard M, Phaneuf D-C, Leveille J. Myocardial perfusion imaging with 99mTcmethoxy- isobutyl-isonitrile (MIBI): Comparison of short and long time intervals between rest and stress injections. Eur Nucl Med. 1988;13:515-522.
- Abrams MJ, Davison A, Jones AG, Costello CE, Pang H. Synthesis and characterization of hexakis (alkyl isocyanide) and hexakis (aryl isocyanide) complexes of technetium (I). Inorg Chem. 1983;22:2798-2800. https://doi.org/10.1021/ic00162a007
- Jeong HJ, Lee DS, Lee HY, Choi S, Han YH, Chung JK. Prognostic Value of Normal Perfusion but Impaired Left Ventricular Function in the Diabetic Heart on Quantitative Gated Myocardial Perfusion SPECT. Nucl Med Mol Iimaging. 2013;47:151-157. https://doi.org/10.1007/s13139-013-0213-9
-
Chung BC, Ryu JK, Cho YK, Kwack DH, Bae HS, Bae YH, et al. Clinical Characterization of Reverse Redistribution Pattern in
$^{99m}TC$ -Sestamibi Myocardial Perfusion Scan. Korean Circulation J. 1999;29:459-464. https://doi.org/10.4070/kcj.1999.29.5.459 -
Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL, et al. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [
$^{18}F$ ] fluorodeoxyglucose. Circulation. 1994;89:578-587. https://doi.org/10.1161/01.CIR.89.2.578 -
Im HJ, Lee IK, Paeng JC, Lee KE, Cheon GJ, Kang KW, et al. Functional evaluation of parathyroid adenoma using
$^{99m}Tc$ -MIBI parathyroid SPECT/CT: correlation with functional markers and disease severity. Nucl Med Commun. 2014;35:649-654. https://doi.org/10.1097/MNM.0000000000000102 - Yoon HJ, Kim Y, Chang KT, Kim BS. Prognostic value of semi-quantitative tumor uptake on Tc-99m sestamibi breast-specific gamma imaging in invasive ductal breast cancer. Ann Nucl Med. 2015;29:553-560. https://doi.org/10.1007/s12149-015-0977-3
-
Suh YJ, Choi JY, Kim SJ, Chun IK, Yun TJ, Lee KE, et al. Comparison of 4D CT, ultrasonography, and
$^{99m}Tc$ sestamibi SPECT/CT in localizing single-gland primary hyperparathyroidism. Otolaryngol Head Neck Surg. 2015;152:438-443. https://doi.org/10.1177/0194599814562195 - Koca G, Atilgan HI, Baskin A, Demirel K, Korkmaz M. Non-visualized Thyroid Gland by Tc-99m MIBI Scan with Normal Thyroid Scan. Nucl Med Mol Iimaging. 2013;47:216-217. https://doi.org/10.1007/s13139-013-0198-4
- Cheon M, Choi JY, Chung JH, Lee JY, Cho SK, Yoo J, et al. Differential findings of tc-99m sestamibi dualphase parathyroid scintigraphy between benign and malignant parathyroid lesions in patients with primary hyperparathyroidism. Nucl Med Mol Iimaging. 2011;45:276-284. https://doi.org/10.1007/s13139-011-0103-y
- Khentigan A, Garrett M, Lum D, Winchell H, et al. Effect of proir administration of Sn(II) complexes used in nuclear medicine on in vivo distribution of subsequently administered Tc-99m pertechnetate and Tc-99m compounds. J Nucl Med; 1975: 16: 541
- Kowalsky RJ, Pharm D. Technetium Radiopharmaceutical Chemistry. New Mexico. 2006:12:25.